IGC Pharma
24 hedge funds and large institutions have $2.19M invested in IGC Pharma in 2020 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
10% more call options, than puts
Call options by funds: $198K | Put options by funds: $180K
0.21% more ownership
Funds ownership: 4.89% → 5.1% (+0.21%)
Holders
24
Holding in Top 10
–
Calls
$198K
Puts
$180K
Top Buyers
| 1 | +$150K | |
| 2 | +$115K | |
| 3 | +$67.6K | |
| 4 |
PIA
Powell Investment Advisors
Miami,
Florida
|
+$26K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$17K |
Top Sellers
| 1 | -$66K | |
| 2 | -$26K | |
| 3 | -$18K | |
| 4 |
SFS
Sowell Financial Services
North Little Rock,
Arkansas
|
-$12.3K |
| 5 |
DP
Dearborn Partners
Chicago,
Illinois
|
-$6.11K |